Disability-Adjusted Life Years (DALYs) provide a comprehensive measure of disease burden by combining mortality and disability. The Global Burden of Disease (GBD) Study 2024 provides the most current estimates for neurodegenerative conditions. This page details the methodology used to calculate and validate DALY estimates for neurodegenerative diseases.
GBD 2024 Framework
DALY Calculation
DALY = YLL + YLD
Where:
YLL (Years of Life Lost) — years lost due to premature mortality
YLD (Years Lived with Disability) — years lived in less than ideal health
Key Parameters
| Parameter | Description | Data Sources | |-----------|-------------|--------------| | Life expectancy | Standard life table (GBD 2024) | WHO Life Tables | | Disability weights | Condition-specific (0 = perfect health, 1 = death) | GBD 2024 Disability Weights Survey | | Prevalence | Number of existing cases | GBD 2024, national registries | | Duration | Average disease duration | GBD 2024, clinical studies |
Disability Weights for Neurodegenerative Diseases
GBD 2024 Disability Weights
...
DALY Methodology — Neurodegeneration
Overview
Disability-Adjusted Life Years (DALYs) provide a comprehensive measure of disease burden by combining mortality and disability. The Global Burden of Disease (GBD) Study 2024 provides the most current estimates for neurodegenerative conditions. This page details the methodology used to calculate and validate DALY estimates for neurodegenerative diseases.
GBD 2024 Framework
DALY Calculation
DALY = YLL + YLD
Where:
YLL (Years of Life Lost) — years lost due to premature mortality
YLD (Years Lived with Disability) — years lived in less than ideal health
Key Parameters
| Parameter | Description | Data Sources | |-----------|-------------|--------------| | Life expectancy | Standard life table (GBD 2024) | WHO Life Tables | | Disability weights | Condition-specific (0 = perfect health, 1 = death) | GBD 2024 Disability Weights Survey | | Prevalence | Number of existing cases | GBD 2024, national registries | | Duration | Average disease duration | GBD 2024, clinical studies |
Disability Weights for Neurodegenerative Diseases
GBD 2024 Disability Weights
| Condition | Disability Weight | 95% CI | Severity Description | |-----------|------------------|--------|---------------------| | Alzheimer's/Dementia (mild) | 0.30 | 0.20-0.42 | Memory problems, difficulty with complex tasks | | Alzheimer's/Dementia (moderate) | 0.55 | 0.38-0.72 | Memory deficits, needs help with daily activities | | Alzheimer's/Dementia (severe) | 0.80 | 0.60-0.94 | Complete dependence, unaware of surroundings | | Parkinson's (mild) | 0.15 | 0.10-0.22 | Some tremor, mild motor impairment | | Parkinson's (moderate) | 0.40 | 0.27-0.54 | Significant motor impairment, some disability | | Parkinson's (severe) | 0.65 | 0.46-0.82 | Severe disability, mobility aid required | | ALS (mild) | 0.35 | 0.23-0.48 | Mild weakness, some functional limitations | | ALS (moderate) | 0.60 | 0.42-0.77 | Significant weakness, needs assistance | | ALS (severe) | 0.85 | 0.68-0.96 | Complete paralysis, ventilator-dependent |
May underestimate quality-of-life impact for some conditions
Weights derived from surveys across multiple regions (validity across cultures)
Updated weights reflect evolving understanding of neurodegenerative burden
YLL Calculation Methodology
Formula
YLL = Σ (Deaths at age a) × (Life expectancy at age a)
For Neurodegenerative Diseases
| Disease | Typical Age at Death | Average YLL | Primary Death Driver | |---------|---------------------|--------------|----------------------| | Alzheimer's | 80-85 years | 5-8 years | Complications (aspiration, infection) | | Parkinson's | 75-80 years | 8-12 years | Respiratory failure, falls | | ALS | 55-65 years | 15-25 years | Respiratory failure | | FTD | 60-70 years | 10-15 years | Complications | | Huntington's | 50-60 years | 20-30 years | Complications |